362 related articles for article (PubMed ID: 19706707)
1. Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells.
Doehle BP; Hladik F; McNevin JP; McElrath MJ; Gale M
J Virol; 2009 Oct; 83(20):10395-405. PubMed ID: 19706707
[TBL] [Abstract][Full Text] [Related]
2. HIV Exploits Antiviral Host Innate GCN2-ATF4 Signaling for Establishing Viral Replication Early in Infection.
Jiang G; Santos Rocha C; Hirao LA; Mendes EA; Tang Y; Thompson GR; Wong JK; Dandekar S
mBio; 2017 May; 8(3):. PubMed ID: 28465428
[TBL] [Abstract][Full Text] [Related]
3. Sustained activation of interferon regulatory factor 3 during infection by paramyxoviruses requires MDA5.
Grandvaux N; Guan X; Yoboua F; Zucchini N; Fink K; Doyon P; Martin L; Servant MJ; Chartier S
J Innate Immun; 2014; 6(5):650-62. PubMed ID: 24800889
[TBL] [Abstract][Full Text] [Related]
4. MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells.
Takaki H; Honda K; Atarashi K; Kobayashi F; Ebihara T; Oshiumi H; Matsumoto M; Shingai M; Seya T
Mol Immunol; 2014 Feb; 57(2):100-10. PubMed ID: 24096085
[TBL] [Abstract][Full Text] [Related]
5. Disruption of Type I Interferon Induction by HIV Infection of T Cells.
Sanchez DJ; Miranda D; Marsden MD; Dizon TM; Bontemps JR; Davila SJ; Del Mundo LE; Ha T; Senaati A; Zack JA; Cheng G
PLoS One; 2015; 10(9):e0137951. PubMed ID: 26375588
[TBL] [Abstract][Full Text] [Related]
6. Peripheral B cells may serve as a reservoir for persistent hepatitis C virus infection.
Ito M; Masumi A; Mochida K; Kukihara H; Moriishi K; Matsuura Y; Yamaguchi K; Mizuochi T
J Innate Immun; 2010; 2(6):607-17. PubMed ID: 20714117
[TBL] [Abstract][Full Text] [Related]
7. Vpu mediates depletion of interferon regulatory factor 3 during HIV infection by a lysosome-dependent mechanism.
Doehle BP; Chang K; Rustagi A; McNevin J; McElrath MJ; Gale M
J Virol; 2012 Aug; 86(16):8367-74. PubMed ID: 22593165
[TBL] [Abstract][Full Text] [Related]
8. Induction of IRF-3 and IRF-7 phosphorylation following activation of the RIG-I pathway.
Paz S; Sun Q; Nakhaei P; Romieu-Mourez R; Goubau D; Julkunen I; Lin R; Hiscott J
Cell Mol Biol (Noisy-le-grand); 2006 May; 52(1):17-28. PubMed ID: 16914100
[TBL] [Abstract][Full Text] [Related]
9. Hantaan virus can infect human keratinocytes and activate an interferon response through the nuclear translocation of IRF-3.
Ye W; Xu Y; Wang Y; Dong Y; Xi Q; Cao M; Yu L; Zhang L; Cheng L; Wu X; Xu Z; Lei Y; Zhang F
Infect Genet Evol; 2015 Jan; 29():146-55. PubMed ID: 25461845
[TBL] [Abstract][Full Text] [Related]
10. Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense.
Johnson CL; Owen DM; Gale M
J Biol Chem; 2007 Apr; 282(14):10792-803. PubMed ID: 17289677
[TBL] [Abstract][Full Text] [Related]
11. RIG-I-mediated antiviral signaling is inhibited in HIV-1 infection by a protease-mediated sequestration of RIG-I.
Solis M; Nakhaei P; Jalalirad M; Lacoste J; Douville R; Arguello M; Zhao T; Laughrea M; Wainberg MA; Hiscott J
J Virol; 2011 Feb; 85(3):1224-36. PubMed ID: 21084468
[TBL] [Abstract][Full Text] [Related]
12. Limited suppression of the interferon-beta production by hepatitis C virus serine protease in cultured human hepatocytes.
Dansako H; Ikeda M; Kato N
FEBS J; 2007 Aug; 274(16):4161-76. PubMed ID: 17651439
[TBL] [Abstract][Full Text] [Related]
13. Synthetic Abortive HIV-1 RNAs Induce Potent Antiviral Immunity.
Stunnenberg M; Sprokholt JK; van Hamme JL; Kaptein TM; Zijlstra-Willems EM; Gringhuis SI; Geijtenbeek TBH
Front Immunol; 2020; 11():8. PubMed ID: 32038656
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
Vazquez C; Tan CY; Horner SM
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of Early Innate Immune Activation during HIV-1 Infection of Humanized Mice.
Skelton JK; Ortega-Prieto AM; Kaye S; Jimenez-Guardeño JM; Turner J; Malim MH; Towers GJ; Dorner M
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867315
[TBL] [Abstract][Full Text] [Related]
16. ISG15 enhances the innate antiviral response by inhibition of IRF-3 degradation.
Lu G; Reinert JT; Pitha-Rowe I; Okumura A; Kellum M; Knobeloch KP; Hassel B; Pitha PM
Cell Mol Biol (Noisy-le-grand); 2006 May; 52(1):29-41. PubMed ID: 16914094
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy.
Binder M; Kochs G; Bartenschlager R; Lohmann V
Hepatology; 2007 Nov; 46(5):1365-74. PubMed ID: 17668876
[TBL] [Abstract][Full Text] [Related]
18. The catcher in the RIG-I.
Weber F
Cytokine; 2015 Nov; 76(1):38-41. PubMed ID: 26168692
[TBL] [Abstract][Full Text] [Related]
19. Pathogen-Associated Molecular Pattern Recognition of Hepatitis C Virus Transmitted/Founder Variants by RIG-I Is Dependent on U-Core Length.
Kell A; Stoddard M; Li H; Marcotrigiano J; Shaw GM; Gale M
J Virol; 2015 Nov; 89(21):11056-68. PubMed ID: 26311867
[TBL] [Abstract][Full Text] [Related]
20. Toll-Like Receptor 2 Ligation Enhances HIV-1 Replication in Activated CCR6+ CD4+ T Cells by Increasing Virus Entry and Establishing a More Permissive Environment to Infection.
Bolduc JF; Ouellet M; Hany L; Tremblay MJ
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
